EU/3/19/2178
About
On 28 June 2019, orphan designation EU/3/19/2178 was granted by the European Commission to Dipharma B.V., The Netherlands, for sodium benzoate, sodium phenylacetate for the treatment of argininosuccinic aciduria.
Key facts
Active substance |
|
Disease / condition |
Treatment of argininosuccinic aciduria
|
Date of first decision |
28/06/2019
|
Outcome |
Positive
|
EU designation number |
EU/3/19/2178
|
Sponsor's contact details
Dipharma B.V.
Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands
Tel. +41 9160 11700
E-mail: info@dipharma-group.com
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: